MarketAxess (NASDAQ: MKTX) CEO receives fresh equity awards

Rhea-AI Filing Summary

MarketAxess Holdings Inc. Chief Executive Officer Christopher R. Concannon reported multiple equity compensation transactions. He acquired 1,696 shares of common stock on February 13, 2026 following certification of performance stock unit metrics, increasing his directly held shares.

On February 15, 2026 he received 6,588 restricted stock units and 21,736 stock options at an exercise price of $179.36 per share, all vesting 34% on February 15, 2027, 33% on February 15, 2028, and 33% on February 15, 2029. On the same date, 866 shares and 1,750 shares were surrendered at $179.36 per share to cover tax withholding obligations upon vesting of performance and restricted stock units, leaving him with 53,949 shares of common stock held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CONCANNON CHRISTOPHER R

(Last) (First) (Middle)

C/O MARKETAXESS HOLDINGS INC.

55 HUDSON YARDS, 15TH FLOOR

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARKETAXESS HOLDINGS INC [ MKTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.003 per share	02/13/2026		A(1)		1,696	A	$0	49,977	D
Common Stock, par value $0.003 per share	02/15/2026		F(2)		866	D	$179.36	49,111	D
Common Stock, par value $0.003 per share	02/15/2026		A		6,588	A	$0(3)	55,699	D
Common Stock, par value $0.003 per share	02/15/2026		F(4)		1,750	D	$179.36	53,949	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$179.36	02/15/2026		A		21,736		(5)	02/15/2032	Common Stock	21,736	$0	21,736	D

Explanation of Responses:

1. On February 13, 2026, the Compensation and Talent Committee of the Board of Directors of the Issuer certified the performance metrics relating to the performance stock units granted to the Reporting Person on February 15, 2023.

2. Represents the surrender of shares to the Company to satisfy the Reporting Person's tax withholding obligation upon the vesting of the performance stock units.

3. Represents a grant of restricted stock units pursuant to the Company's 2020 Equity Incentive Plan. The restricted stock units shall vest 34% on February 15, 2027, 33% on February 15, 2028, and 33% on February 15, 2029.

4. Represents the surrender of shares to the Company to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units previously granted to the Reporting Person.

5. The stock options shall vest 34% on February 15, 2027, 33% on February 15, 2028, and 33% on February 15, 2029.

	/s/ Patrick Wilson as Attorney-in-Fact for Christopher R. Concannon	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MKTX CEO Christopher Concannon report on this Form 4?

Christopher Concannon reported equity compensation activity, not open-market trades. He acquired common shares from performance stock units, received new restricted stock units and stock options, and surrendered shares back to MarketAxess to cover tax withholding obligations related to vesting awards.

How many restricted stock units did the MKTX CEO receive in this filing?

The CEO received 6,588 restricted stock units. These were granted under MarketAxess’s 2020 Equity Incentive Plan and are scheduled to vest 34% on February 15, 2027, 33% on February 15, 2028, and 33% on February 15, 2029, subject to continued service.

What stock options were granted to the MKTX CEO and at what price?

The CEO was granted 21,736 stock options with an exercise price of $179.36 per share. These options vest in tranches of 34% on February 15, 2027, 33% on February 15, 2028, and 33% on February 15, 2029, if vesting conditions are met.

Were any MKTX shares sold by the CEO on the open market in this Form 4?

No open-market sales were reported. The Form 4 shows share surrenders coded as “F” transactions, where 866 shares and 1,750 shares were delivered back to the company solely to satisfy tax withholding obligations upon vesting of equity awards.

How many MKTX common shares does the CEO hold after these transactions?

After the reported transactions, Christopher Concannon directly holds 53,949 shares of MarketAxess common stock. This figure reflects the net result of equity award-related share acquisitions and the shares surrendered to the company for tax withholding obligations in February 2026.

What triggered the 1,696-share acquisition reported for the MKTX CEO?

The 1,696-share acquisition followed certification of performance metrics. On February 13, 2026, MarketAxess’s Compensation and Talent Committee certified performance metrics tied to performance stock units granted on February 15, 2023, resulting in common shares being delivered to the CEO.